Advanced search
Publication Cover
Immunopharmacology and Immunotoxicology Volume 38, 2016 - Issue 3
Submit an article Journal homepage
129
Views
9
CrossRef citations to date
0
Altmetric
Research Article

Pristimerin attenuates ovalbumin-induced allergic airway inflammation in mice

Yingli JinDepartment of Pharmacology, College of Basic Medical Science, Jilin University, Changchun, People’s Republic of China;
,
Yujia WangCollege of Food Science and Engineering, Jilin University, Changchun, Jilin, People’s Republic of China
,
Danning ZhaoCollege of Food Science and Engineering, Jilin University, Changchun, Jilin, People’s Republic of China
,
Sitong MaCollege of Food Science and Engineering, Jilin University, Changchun, Jilin, People’s Republic of China
,
Jing LuCollege of Food Science and Engineering, Jilin University, Changchun, Jilin, People’s Republic of ChinaCorrespondence[email protected] [email protected]
&
Guan ShuangCollege of Food Science and Engineering, Jilin University, Changchun, Jilin, People’s Republic of ChinaCorrespondence[email protected] [email protected]
Pages 221-227 | Received 19 Dec 2015, Accepted 16 Mar 2016, Published online: 21 Apr 2016

Citations (9)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Dina S El-Agamy, Khaled M El-Harbi, Saad Khoshhal, Nishat Ahmed, Mohamed A Elkablawy, Ahmed A Shaaban & Hany M Abo-Haded. (2019) Pristimerin protects against doxorubicin-induced cardiotoxicity and fibrosis through modulation of Nrf2 and MAPK/NF-kB signaling pathways. Cancer Management and Research 11, pages 47-61.
Read now

Articles from other publishers (8)

Dongsheng Huang, Lianhui Su, Chaowen He, Licheng Chen, Dongxuan Huang, Jianfeng Peng, Fan Yang, Yahui Cao & Xiaohua Luo. (2022) Pristimerin alleviates cigarette smoke-induced inflammation in chronic obstructive pulmonary disease via inhibiting NF-κB pathway. Biochemistry and Cell Biology 100:3, pages 223-235.
Crossref
Gülin Renda, İçim Gökkaya & Didem Şöhretoğlu. (2021) Immunomodulatory properties of triterpenes. Phytochemistry Reviews 21:2, pages 537-563.
Crossref
Run-Ze Chen, Fei Yang, Min Zhang, Zhi-Gang Sun & Nan Zhang. (2021) Cellular and Molecular Mechanisms of Pristimerin in Cancer Therapy: Recent Advances. Frontiers in Oncology 11.
Crossref
Minxiu Tian, Shuai Peng, Shanshan Wang, Xiangjie Li, Huimin Li & Lei Shen. (2021) Pristimerin reduces dextran sulfate sodium-induced colitis in mice by inhibiting microRNA-155. International Immunopharmacology 94, pages 107491.
Crossref
Dahu Qi, Hui Liu, Xuying Sun, Danni Luo, Meipeng Zhu, Tenghui Tao, Chenghao Gao, Chuankun Zhou, Wei Zhou & Jun Xiao. (2021) Pristimerin Suppresses RANKL-Induced Osteoclastogenesis and Ameliorates Ovariectomy-Induced Bone Loss. Frontiers in Pharmacology 11.
Crossref
Qun Zhao, Yun Bi, Jing Zhong, Ziting Ren, Yingxiang Liu, Junjun Jia, Mengting Yu, Yan Tan, Qiufang Zhang & Xianjun Yu. (2020) Pristimerin suppresses colorectal cancer through inhibiting inflammatory responses and Wnt/β-catenin signaling. Toxicology and Applied Pharmacology 386, pages 114813.
Crossref
Ahmed A. Shaaban, Dalia H. El-Kashef, Mohamed F. Hamed & Dina S. El-Agamy. (2018) Protective effect of pristimerin against LPS-induced acute lung injury in mice. International Immunopharmacology 59, pages 31-39.
Crossref
Dina S. El-Agamy, Ahmed A. Shaaban, Hamdi H. Almaramhy, Sarah Elkablawy & Mohamed A. Elkablawy. (2018) Pristimerin as a Novel Hepatoprotective Agent Against Experimental Autoimmune Hepatitis. Frontiers in Pharmacology 9.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.